|
SEVERABLE FUNDING FOR NCI-FREDERICK
|
261200800001E
|
$248,730,791
|
$1,181
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Cancer Center Support Grant
|
5P30CA015704-41
|
$9,561,228
|
$95,612
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Moffitt Cancer Center Support Grant
|
4P30CA076292-18
|
$2,930,104
|
$29,301
|
SELLERS, THOMAS
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Risk of Pediatric and Adolescent Cancer Associated with Medical Imaging
|
5R01CA185687-04
|
$2,139,085
|
|
SMITH-BINDMAN, REBECCA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Systems Analysis of Epigenomic Architecture in Cancer Progression
|
5U54CA217297-02
|
$2,104,443
|
|
HUANG, TIM
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
MOTILITY AND INVASION
|
5P01CA100324-16
|
$2,028,990
|
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
|
5P01CA117969-13
|
$1,980,694
|
|
DEPINHO, RONALD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Roles and Regulation of wild-type and mutant forms of p53
|
5P01CA087497-17
|
$1,885,586
|
|
PRIVES, CAROL
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
Defining RAS isoform- and mutation-specific roles in oncogenesis
|
5P01CA203657-03
|
$1,539,964
|
|
DER, CHANNING
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
The Biology of Prostate Cancer Skeletal Metastases
|
5P01CA093900-14
|
$1,510,770
|
|
KELLER, EVAN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-18S3
|
$1,479,340
|
$14,793
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Proteogenomic studies aimed at understanding ovarian tumor responses to agents targeting the DNA damage response and translating this knowledge into clinical benefit
|
5U01CA214114-02
|
$1,441,604
|
|
PAULOVICH, AMANDA
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
MICROSCALED PROTEOGENOMICS FOR CANCER CLINICAL TRIALS
|
5U01CA214125-02
|
$1,413,657
|
|
ELLIS, MATTHEW
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE University of Texas M. D. Anderson Cancer Center-Leukemia
|
2P50CA100632-16
|
$1,392,864
|
|
KANTARJIAN, HAGOP
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Genetic Determinants of Barretts Esophagus and Esophageal Adenocarcinoma
|
5U54CA163060-07
|
$1,283,594
|
|
CHAK, AMITABH
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Investigating the development of AIDs and non-AIDS defining cancers in aged SIV-infected rhesus macaques.
|
5R01CA206404-03
|
$1,263,878
|
|
WONG, SCOTT
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Adult Brain Tumor Consortium (ABTC)
|
5UM1CA137443-09
|
$1,244,620
|
|
GROSSMAN, STUART
|
JOHNS HOPKINS UNIVERSITY
|
|
High-throughput sequencing to identify novel melanoma susceptibility genes
|
5R01CA195614-04
|
$1,075,363
|
|
HUFF, CHAD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Metabolic basis of B cell lineage leukemia relapse
|
5R35CA197628-03
|
$1,035,561
|
|
MUSCHEN, MARKUS
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-18S5
|
$1,000,000
|
$10,000
|
SELLERS, THOMAS
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
2/2 NCCU-LCCC Partnership in Cancer Research
|
5U54CA156733-07
|
$997,277
|
$19,946
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Promoting follow-up of abnormal cancer screening tests using population-basedsystems to support stepped care multilevel intervention
|
1U01CA225451-01
|
$976,725
|
|
HAAS, JENNIFER
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Emory, Harvard & Univ. of Washington Prostate Cancer Biomarker Center
|
5U01CA113913-13
|
$861,492
|
|
SANDA, MARTIN
|
EMORY UNIVERSITY
|
|
OSU K12 Training Grant for Clinical Faculty Investigators
|
5K12CA133250-10
|
$793,532
|
|
BYRD, JOHN
|
OHIO STATE UNIVERSITY
|
|
Systems Modeling of Tumor Heterogeneity and Therapy Response in Colorectal Cancer
|
5R01CA208179-02
|
$765,244
|
|
GINTY, FIONA
|
GENERAL ELECTRIC GLOBAL RESEARCH CTR
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-18S5
|
$749,999
|
$7,500
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA015704-41S7
|
$749,998
|
$7,500
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
(PQ8) Genetically faithful murine models for studying disease progression in chronic lymphocytic leukemia
|
5R01CA216273-02
|
$740,321
|
|
WU, CATHERINE
|
DANA-FARBER CANCER INST
|
|
Identification of genomic drivers of brain metastases in lung adenocarcinoma
|
1R01CA227156-01
|
$729,700
|
|
BRASTIANOS, PRISCILLA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Automated Platform for Fixed Tissue Microdissection
|
5R44CA199194-03
|
$718,448
|
|
KARSTEN, STANISLAV
|
NEUROINDX INC.
|
|
(PQ3) Identifying Novel Pharmacologic Risk factors for Common Non-AIDS Defining Cancers in Individuals with Well-controlled HIV Infection
|
5R01CA206476-03
|
$706,386
|
|
CHIAO, ELIZABETH
|
BAYLOR COLLEGE OF MEDICINE
|
|
Exploring PSMA Biology in Tumor neovasculature
|
5R01CA212379-02
|
$704,122
|
|
GRIMM, JAN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Testicular effects of modern chemotherapy regimens in osteosarcoma survivors
|
1R01CA175216-01A1
|
$699,129
|
$349,565
|
SHNORHAVORIAN, MARGARETT
|
SEATTLE CHILDREN'S HOSPITAL
|
|
Advanced Development of an Open-source Platform for Web-based Integrative Digital Image Analysis in Cancer
|
5U24CA194362-04
|
$687,048
|
|
GUTMAN, DAVID
|
EMORY UNIVERSITY
|
|
Signal Transduction by Tyrosine Phosphorylation
|
5R01CA082683-19
|
$674,327
|
|
HUNTER, TONY
|
SALK INSTITUTE FOR BIOLOGICAL STUDIES
|
|
Multiscale Modeling of Bone Environment Responses to Metastatic Prostate Cancer
|
5U01CA202958-03
|
$668,427
|
|
BASANTA GUTIERREZ, DAVID
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Genetic Epidemiology of non-Hodgkin Lymphoma
|
5R01CA200703-03
|
$660,329
|
|
CERHAN, JAMES
|
MAYO CLINIC ROCHESTER
|
|
Dynamics of Gene and Isoform Regulation during EMT and tumor progression
|
5U01CA184897-05
|
$657,975
|
|
GERTLER, FRANK
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Likes Pins and Views: Engaging Moms on Teen Indoor Tanning Thru Social Media
|
5R01CA192652-04
|
$655,776
|
|
BULLER, DAVID
|
KLEIN BUENDEL, INC.
|
|
Integrating Radiomics into S0819 and Lung-MAP, Biomarker Driven Clinical Trials for Lung Cancer
|
1U01CA225431-01
|
$644,727
|
|
SCHWARTZ, LAWRENCE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Late Effects of Treatment in Wilms Tumor Survivors and Offspring
|
4R01CA054498-25
|
$636,039
|
$127,208
|
LEISENRING, WENDY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Enhancing Adoptive Immunotherapy Targeting Pediatric High-Grade Gliomas
|
5R01CA195563-04
|
$633,869
|
|
MITCHELL, DUANE
|
UNIVERSITY OF FLORIDA
|
|
Novel immunological biomarkers ovarian cancer prognosis
|
5R01CA188900-04
|
$632,858
|
|
SEGAL, BRAHM
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Integrative approach to heterogeneity in breast cancer metastasis
|
5U01CA199315-03
|
$623,888
|
|
WERB, ZENA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Physicians Perceptions, Attitudes, and Communication of E-Cigarettes (PACE)
|
5R01CA190444-04
|
$612,501
|
|
DELNEVO, CRISTINE
|
RBHS-SCHOOL OF PUBLIC HEALTH
|
|
Integrating bioinformatics into multiscale models for hepatocellular carcinoma
|
1U01CA212007-01A1
|
$607,918
|
|
FERTIG, ELANA
|
JOHNS HOPKINS UNIVERSITY
|
|
A Randomized Controlled Trial of an HPV Vaccine Intervention for Young Sexual Minority Men
|
1R37CA226682-01
|
$602,822
|
|
REITER, PAUL
|
OHIO STATE UNIVERSITY
|
|
NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention
|
5R01CA169175-05
|
$579,176
|
$115,835
|
SCHEDIN, PEPPER
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Exploring the Role of Mitochondrial Fission in Pancreatic Tumorigenesis
|
5R01CA200755-03
|
$548,299
|
|
KASHATUS, DAVID
|
UNIVERSITY OF VIRGINIA
|
|
Phase I trial of intravenous vesicular stomatitis virus for treatment of metastatic endometrial cancer
|
5R01CA207240-02
|
$543,708
|
|
BAKKUM-GAMEZ, JAMIE
|
MAYO CLINIC ROCHESTER
|
Total relevant funding to Contraception and Reproduction Research for this search: $1,333,375
|